{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T14:52:42Z","timestamp":1782571962604,"version":"3.54.5"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Neurosurg"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Majority of acute cervical spinal cord injury end up requiring long-term stay in intensive care unit (ICU). During the initial few days after spinal cord injury, most patients are hemodynamically unstable requiring intravenous vasopressors. However, many studies have noted that long-term intravenous vasopressors remain the main reason for prolongation of ICU stay. In this series, we report the effect of using oral midodrine in reducing the amount and duration of intravenous vasopressors in patients with acute cervical spinal cord injury.<\/jats:p><jats:p>\n          Materials and Methods\u2003Five adult patients with cervical spinal cord injury after initial evaluation and surgical stabilization are assessed for the need for intravenous vasopressors. If patients continue to need intravenous vasopressors for more than 24\u2009hours, they were started on oral midodrine. Its effect on weaning of intravenous vasopressors was assessed.<\/jats:p><jats:p>\n          Results\u2003Patients with systemic and intracranial injury were excluded from the study. Midodrine helped in weaning of intravenous vasopressors in the first 24 to 48\u2009hours and helped in complete weaning of intravenous vasopressors. The rate of reduction was between 0.5 and 2.0 \u00b5g\/min.<\/jats:p><jats:p>\n          Conclusion\u2003Oral midodrine does have an effect in reduction of intravenous vasopressors for patients needing prolonged support after cervical spine injury. The real extent of this effect needs to be studied with collaboration of multiple centers dealing with spinal injuries. The approach seems to be a viable alternative to rapidly wean intravenous vasopressors and reduce duration of ICU stay.<\/jats:p>","DOI":"10.1055\/s-0043-1769755","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T23:21:32Z","timestamp":1686957692000},"page":"306-311","source":"Crossref","is-referenced-by-count":3,"title":["Oral Midodrine as an Adjunct in Rapid Weaning of Intravenous Vasopressor Support in Spinal Cord Injury"],"prefix":"10.1055","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-6620","authenticated-orcid":false,"given":"Arunkumar","family":"Sekar","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences \u2013 Bhubaneswar, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Datta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences \u2013 Bhubaneswar, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Lakha","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences \u2013 Bhubaneswar, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sritam Swaroop","family":"Jena","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, All India Institute of Medical Sciences \u2013 Bhubaneswar, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences \u2013 Bhubaneswar, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabi Narayan","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, All India Institute of Medical Sciences \u2013 Bhubaneswar, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40360-016-0063-z","article-title":"Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study","volume":"17","author":"C Thongprayoon","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"issue":"24","key":"ref2","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1089\/neu.2015.3903","article-title":"Contemporary cardiovascular concerns after spinal cord injury: mechanisms, maladaptations, and management","volume":"32","author":"A A Phillips","year":"2015","journal-title":"J Neurotrauma"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-444-52137-8.00013-9","volume-title":"Disordered cardiovascular control after spinal cord injury [Internet]","author":"L C Weaver","year":"2012"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1227\/01.neu.0000430319.32247.7f","article-title":"Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update","volume":"60","author":"B C Walters","year":"2013","journal-title":"Neurosurgery"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3171\/2017.7.FOCUS17396","article-title":"Update on critical care for acute spinal cord injury in the setting of polytrauma","volume":"43","author":"J K Yue","year":"2017","journal-title":"Neurosurg Focus"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.apmr.2013.03.028","article-title":"Hemodynamic effects of L-threo-3,4-dihydroxyphenylserine (Droxidopa) in hypotensive individuals with spinal cord injury","volume":"94","author":"J M Wecht","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/FOC.2008.25.11.E13","article-title":"Cardiovascular complications after acute spinal cord injury: pathophysiology, diagnosis, and management","volume":"25","author":"J C Furlan","year":"2008","journal-title":"Neurosurg Focus"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"84S","DOI":"10.1177\/2192568217703387","article-title":"A clinical practice guideline for the management of acute spinal cord injury: introduction, rationale, and scope","volume":"7","author":"M G Fehlings","year":"2017","journal-title":"Global Spine J"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/BSD.0000000000000287","article-title":"Acute spinal cord injury","volume":"28","author":"C D Witiw","year":"2015","journal-title":"J Spinal Disord Tech"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10790268.2008.11760744","article-title":"Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals","volume":"31","author":"Consortium for Spinal Cord Medicine","year":"2008","journal-title":"J Spinal Cord Med"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3892\/mmr.2021.12056","article-title":"Acute spinal cord injury: pathophysiology and pharmacological intervention (Review)","volume":"23","author":"Y Zhang","year":"2021","journal-title":"Mol Med Rep"},{"issue":"03","key":"ref12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/neu.2016.4947","article-title":"Incidence and natural progression of neurogenic shock after traumatic spinal cord injury","volume":"35","author":"I A Ruiz","year":"2018","journal-title":"J Neurotrauma"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10286-016-0363-9","article-title":"Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study","volume":"26","author":"W Smith","year":"2016","journal-title":"Clin Auton Res"},{"key":"ref14","first-page":"428","article-title":"[Treatment of hypotension in general practice with Gutron]","volume":"125","author":"V K Lacbnit","year":"1975","journal-title":"Wien Med Wochenschr"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","article-title":"A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension","volume":"51","author":"R A Wright","year":"1998","journal-title":"Neurology"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/hrt.79.1.45","article-title":"Midodrine: a role in the management of neurocardiogenic syncope","volume":"79","author":"C R Ward","year":"1998","journal-title":"Heart"},{"issue":"07","key":"ref17","first-page":"429","article-title":"Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome","volume":"56","author":"A Schirger","year":"1981","journal-title":"Mayo Clin Proc"},{"issue":"05","key":"ref18","first-page":"757","article-title":"Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders","volume":"38","author":"D McTavish","year":"1989","journal-title":"Drugs"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00134-020-06216-x","article-title":"Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial","volume":"46","author":"P Santer","year":"2020","journal-title":"Intensive Care Med"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00134-020-06321-x","article-title":"Midodrine administration during critical illness: fixed-dose or titrate to response?","volume":"47","author":"R R Riker","year":"2021","journal-title":"Intensive Care Med"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jcrc.2013.05.021","article-title":"Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions","volume":"28","author":"A R Levine","year":"2013","journal-title":"J Crit Care"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.chest.2016.02.657","article-title":"Feasibility, utility, and safety of midodrine during recovery phase from septic shock","volume":"149","author":"M R Whitson","year":"2016","journal-title":"Chest"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jcpt.12375","article-title":"Midodrine for the weaning of vasopressor infusions","volume":"41","author":"L B Poveromo","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"08","key":"ref24","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1097\/CCM.0000000000003814","article-title":"Continuation of newly initiated midodrine therapy after intensive care and hospital discharge: a single-center retrospective study","volume":"47","author":"M S Rizvi","year":"2019","journal-title":"Crit Care Med"}],"container-title":["Asian Journal of Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1769755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:29:27Z","timestamp":1688081367000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1769755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":24,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2023,6,29]]},"published-print":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1769755","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1793-5482","2248-9614"],"issn-type":[{"value":"1793-5482","type":"print"},{"value":"2248-9614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}